Phase 2 FOLFOX Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Multicenter, Randomized Controlled Phase II Study of Short-Course Radiotherapy Followed by Sequential PD-1 Inhibitor and FOLFOX Chemotherapy Versus Long-Course Chemoradiotherapy for High-Risk Locally Advanced pMMR/MSS Lower Rectal Adenocarcinoma (STAR Trial)
Rectal AdenocarcinomaImmunotherapyHigh-risk Locally Advanced+2 more
Sixth Affiliated Hospital, Sun Yat-sen University76 enrolled1 locationNCT07669220
Recruiting
Phase 2
Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer
Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX
Lithuanian University of Health Sciences250 enrolled1 locationNCT05378919